Evaluación comparativa de las pruebas de diagnóstico ELISA e inmunocromatografía para detección de HBsAg en infección por VHB confirmada por PCR

Evaluación comparativa de las pruebas de diagnóstico ELISA e inmunocromatografía para detección de HBsAg en infección por VHB confirmada por PCR

Resumen: Introducción y objetivos: La hepatitis viral aparece más frecuentemente al nacer o durante la infancia y es una enfermedad cuyas vías de transmisión incluyen lágrimas, bilis, fluidos sexuales, sudor, leche, orina, heces y saliva. El objetivo del presente estudio fue analizar la especificid...

Full description

Bibliographic Details
Main Authors:	N. Navvabi, M.H. Khadem Ansari, A. Navvabi, H.R. Chalipa, F. Zitricky
Format:	Article
Language:	Spanish
Published:	Elsevier 2022-04-01
Series:	Revista de Gastroenterología de México
Subjects:	Hepatitis B virus Immunochromatography Enzyme Linked Immunosorbent Assays Polymerase chain reaction Hepatitis B Surface Antigen
Online Access:	http://www.sciencedirect.com/science/article/pii/S0375090621000690

Similar Items

Performance Evaluation of an Improved HBsAg Assay (HBsAg NEXT) for the Detection of HBsAg Levels
by: Ekta Gupta, et al.
Published: (2023-12-01)

Seroconversion among children with HBsAg-positive mothers in Indonesia and factors affecting the anti-HBs titers
by: Angga Wirahmadi, et al.
Published: (2024-06-01)

Lower end of treatment HBsAg and HBcrAg were associated with HBsAg loss after nucleos(t)ide analog cessation
by: Yandi Xie, et al.
Published: (2023-06-01)

Correlation between serum quantitative HBsAg and HBV DNA levels in chronic hepatitis B patients
by: Pete Maria, et al.
Published: (2023-01-01)

Change of HBsAg Screening and Seropositivity in Pregnant Women By the Years
by: Gökhan TOSUN, et al.
Published: (2019-12-01)

A human monoclonal antibody against HBsAg for the prevention and treatment of chronic HBV and HDV infection
by: Rani Burm, et al.
Published: (2023-03-01)

Comparison of the elecsys HBsAg II assay and the architect assay for quantification of hepatitis B surface antigen in chronic hepatitis B patients
by: Chen-Chih Liao, et al.
Published: (2015-06-01)

Role of HBsAg Neutralisation Test in Low Positive and Indeterminate HBsAg Results by Electrochemiluminescence
by: Mridula Madiyal, et al.
Published: (2024-03-01)

Protracted HBsAg-aemia in a Patient with Acute Hepatitis B
by: K. R. Dudina, et al.
Published: (2018-11-01)

Hepatocellular Carcinoma in Hepatitis B Virus-Infected Patients and the Role of Hepatitis B Surface Antigen (HBsAg)
by: Satinder P. Kaur, et al.
Published: (2022-02-01)

HBsAg protein composition and clinical outcomes in chronic hepatitis D and variations across HBeAg-negative chronic HBsAg carriers
by: Luisa Roade, et al.
Published: (2023-10-01)

Low prevalence of hepatitis delta infection in Cuban HBsAg carriers: Prospect for elimination
by: Licel de los Ángeles Rodríguez Lay, et al.
Published: (2023-02-01)

HBsAg loss with HBsAg/anti-HBs seroconversion and non-detectable HCV-RNA in a patient with chronic HBV e-minus/HCV hepatitis treated with two cycles of antiviral therapy
by: Antonio Salvio, et al.
Published: (2012-01-01)

Anti-HBc: a significant host predictor of spontaneous HBsAg seroclearance in chronic hepatitis B patients - a retrospective longitudinal study
by: Karin Kan, et al.
Published: (2023-10-01)

Quantitative HBsAg versus HBV DNA in Predicting Significant Hepatitis Activity of HBeAg-Positive Chronic HBV Infection
by: Zhanqing Zhang, et al.
Published: (2021-11-01)

Seroprevalence of HBsAg, Anti-HBs, anti-HDV and HDVAg in Inonu University Medical Faculty Hospital, 2012 [Inonu Universitesi Tip Fakultesi Hastanesinde, 2012 Yilinda, HBsAg, Anti-HBs, Anti-HDV ve HDVAg Seroprevalansi]
by: Yucel Duman, et al.
Published: (2014-03-01)

Seroprevalence of hepatitis B virus surface antigen (HBsAg) in Egypt (2000–2022): a systematic review with meta-analysis
by: Ahmed Azzam, et al.
Published: (2023-03-01)

Characteristics and clinical treatment outcomes of chronic hepatitis B children with coexistence of hepatitis B surface antigen (HBsAg) and antibodies to HBsAg
by: Yingping Gu, et al.
Published: (2024-02-01)

HBsAg Loss as a Treatment Endpoint for Chronic HBV Infection: HBV Cure
by: Maryam Moini, et al.
Published: (2022-03-01)

Efficacy of combined HBsAg, anti-HBc and anti-HBs screening in minimizing transfusion transmission risk of hepatitis B infection in low resource setting
by: Shreyasi Athalye, et al.
Published: (2024-02-01)

Different Kinetics of HBV-DNA and HBsAg in HCV Coinfected Patients during DAAs Therapy
by: Piero Colombatto, et al.
Published: (2022-03-01)

Cloning of HBsAg Gene of Hepatitis B Virus in to an Expression Vector
by: Aykut ÖZDARENDELİ, et al.
Published: (2003-09-01)

The prevalence of HBsAg among pregnant women referred to Kerman maternity hospitals in 1997
by: B.SH Ali
Published: (1999-03-01)

Incidência pós-transfusional do HBsAg em crianças com doenças neoplásicas Post-transfusional incidence of HBsAg in children with neoplastic diseases
by: Maria Zélia Fernandes, et al.
Published: (2009-04-01)

Seroprevalence of HBsAg, Anti-HBs, Anti-HCV and Anti-HIV in Behçet’s Disease
by: Cahit Yavuz, et al.
Published: (2021-09-01)

Performance evaluation of the Access HBsAg and Access HBsAg confirmatory assays on the DxI 9000 Access Immunoassay Analyzer
by: Benoit Visseaux, et al.
Published: (2024-03-01)

The potential effect of HBV vaccination on off-treatment HBsAg reversion after interferon-induced HBsAg clearance
by: Shaowen Jiang, et al.
Published: (2023-01-01)

Profile of Hepatitis B Virus Mutations Associated with HBsAg-Negative Disease in Patients of Hemodialysis Centers
by: Yu. V. Ostankova, et al.
Published: (2022-01-01)

Seroprevalence of HBsAg, Anti-HIV1/2 and Anti-HCV in Pregnancies at Ege University Medical Faculty Hospital
by: İmre ALTUĞLU, et al.
Published: (2017-09-01)

HBsAg quantification predicts off-treatment response to interferon in chronic hepatitis B patients: a retrospective study of 250 cases
by: Shuai Wu, et al.
Published: (2020-04-01)

Correlation Between Vitamin D Status and HBsAg Antibody Levels in Indonesian Adolescents Immunised Against Hepatitis B
by: Girsang RT, et al.
Published: (2023-11-01)

Clinical outcomes of treatment-naïve HBeAg-negative patients with chronic hepatitis B virus infection with low serum HBsAg and undetectable HBV DNA
by: Jian Wang, et al.
Published: (2024-12-01)

SEROPREVALENCE OF HBsAg, Anti-HBs, Anti-HCV, and Anti-HIV IN PATIENTS WITH ALCOHOL AND SUBSTANCE ABUSE IN AN AMATEM CLINIC IN EASTERN TURKIYE: A SIX-YEAR RETROSPECTIVE EVALUATION
by: Nülüfer Kılıç, et al.
Published: (2022-11-01)

The Prevalence of Hepatitis B Surface Antigen (HBsAg) and its Influencing Factors in Pregnant Women Referring to Healthcare Centers of Dehloran, Iran in 2011-2012
by: Leila Kheiri, et al.
Published: (2015-06-01)

A simple-to-use score system for predicting HBsAg clearance to peginterferon alfa-2b in nucleoside analogs-experienced chronic hepatitis B patients
by: Kaimin Song, et al.
Published: (2023-11-01)

Poly(Ethylene Glycol)-Poly(Lactic Acid) TLR7 Agonist as a Novel HBsAg Immune Response Stimulant
by: BRYAN GERVAIS DE LIYIS, et al.
Published: (2023-03-01)

Hepatitis A and Hepatitis E Virus Seropositivity in Patients with Hepatitis B Surface Antigen (HBsAg) Positivity
by: Esma Kepenek Kurt, et al.
Published: (2022-09-01)

RESULTS OF GENOTYPING HEPATITIS VIRUS B IN HBsAg-NEGATIVE BLOOD DONORS IN ASTANA, KAZAKHSTAN
by: Yu. V. Ostankova, et al.
Published: (2018-01-01)

Diagnostic precision of Truenat® technique and co-relation of ALT levels with HBV-DNA viral load among HBsAg positive patients at a tertiary care hospital in Eastern Uttar Pradesh
by: Sarita Kumari, et al.
Published: (2024-02-01)

Evaluation of Risk Factors Associated with HBsAg and Anti- HCV Seropositivity: Results of a Nationwide Population-based Epidemiological Survey Study in Turkey
by: Selma TOSUN, et al.
Published: (2018-12-01)